COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced that data from a pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results